Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Francis Medical Inc.
Age
45–80
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
45-80 years old
Biopsy confirmed unilateral, adenocarcinoma of the prostate
Minimum of 12 biopsy cores obtained ≥4 weeks and ≤12 months before treatment. Targeted fusion biopsy is preferred if there is a MRI PI-RADs ≥3 lesion. It is preferred a standard 12 sector biopsy is mapped. MRI required if biopsy was completed \>6 months prior to treatment date to confirm no MRI progression of disease that would be considered exclusionary.
≤4 of 6 standard sector biopsy cores positive for prostate cancer (unilateral); positive core(s) from a targeted lesion count as one positive core.
Gleason score of 7 (3+4) / International Society of Urological Pathologists (ISUP) Gleason Grade Group (GGG) 2
Clinical Stage less than or equal to T2b N0 M0
PSA (Prostate Specific Antigen) less than or equal to 15ng/mL
Prostate size 20-80cc
You may not be if
Malignant tumors identified by extraprostatic extension, sphincter involvement/lesion abutment seminal vesicle invasion or lymph node invasion or metastasis
Narrow Peripheral Zone
MRI identified PI-RADs ≥4 lesion contralateral to the side that has biopsy confirmed adenocarcinoma
Prior definitive treatment of prostate cancer
Clareo Health | Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer
